Intravenous thrombolysis in acute ischemic stroke: standard and potential future applications

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Expert Review of Neurotherapeutics

• Publication date

  2014-07-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/14737175.2014.934676PMID 24984941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data

  2015cited by this paper
• The Role of Sonolysis and Sonothrombolysis in Acute Ischemic Stroke: A Systematic Review and Meta‐analysis of Randomized Controlled Trials and Case‐Control Studies

  2014influential reference
• Thrombolysis in patients with lacunar stroke is safe: an observational study

  2014cited by this paper
• Abstract T MP34: Correlates of Clot Length Assessed by Thin-Section CT in a Consecutive Series of Stroke Patients

  2014cited by this paper
• Advancements in understanding the mechanisms of symptomatic lacunar ischemic stroke: translation of knowledge to prevention strategies

  2014cited by this paper
• Stroke: new horizons in treatment.

  2014cited by this paper
• Thrombolysis for Acute Ischaemic Stroke with Alteplase in an Asian Population: Results of the Multicenter, Multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World (SITS-NEW)

  2014cited by this paper
• Intravenous Thrombolysis for Acute Ischemic Stroke Occurring during Hospitalization for Transient Ischemic Attack

  2014influential reference
• Sonothrombolysis for Acute Ischemic Stroke

  2013cited by this paper
• Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke–Enhanced Regimen Stroke Trial

  2013cited by this paper
• Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.

  2013cited by this paper
• Review, Historical Context, and Clarifications of the NINDS rt-PA Stroke Trials Exclusion Criteria: Part 1 Rapidly Improving Stroke Symptoms

  2013cited by this paper
• A trial of imaging selection and endovascular treatment for ischemic stroke.

  2013cited by this paper
• Stroke: advances in thrombolysis.

  2013cited by this paper
• Clot Length Distribution and Predictors in Anterior Circulation Stroke: Implications for Intra-Arterial Therapy

  2013cited by this paper
• Prestroke dementia is associated with poor outcomes after reperfusion therapy among elderly stroke patients.

  2013cited by this paper
• Emerging issues in acute ischemic stroke

  2013cited by this paper
• Endovascular treatment for acute ischemic stroke.

  2013cited by this paper
• Prehospital thrombolysis in acute stroke

  2013cited by this paper
• Temporal trends in acute stroke management.

  2013cited by this paper
• The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study.

  2012cited by this paper
• Symptomatic intracranial hemorrhage after stroke thrombolysis: The SEDAN Score

  2012cited by this paper
• Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

  2012influential reference
• Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial

  2012cited by this paper
• Statistical Analysis Plan for the Third International Stroke Trial (IST-3); Part of a ‘Thread’ of Reports of the Trial

  2012cited by this paper
• A Multicentre, Randomized, Double-Blinded, Placebo-Controlled Phase III Study to Investigate Extending the Time for Thrombolysis in Emergency Neurological Deficits (EXTEND)

  2012cited by this paper
• Sonothrombolysis for acute ischaemic stroke.

  2012cited by this paper
• Thrombolysis in acute ischaemic stroke.

  2012cited by this paper
• Intravenous Thrombolysis and Endovascular Therapy for Acute Ischemic Stroke With Internal Carotid Artery Occlusion: A Systematic Review of Clinical Outcomes

  2012cited by this paper
• Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial.

  2012cited by this paper
• rt-PA for ischaemic stroke: what will the next question be?

  2012cited by this paper
• In Anticipation of International Stroke Trial-3 (IST-3)

  2012influential reference
• TESPI (Thrombolysis in Elderly Stroke Patients in Italy): A Randomized Controlled Trial of Alteplase (Rt-PA) versus Standard Treatment in Acute Ischaemic Stroke in Patients Aged more than 80 Years Where Thrombolysis is Initiated within Three Hours after Stroke Onset

  2012cited by this paper
• Reducing in-hospital delay to 20 minutes in stroke thrombolysis

  2012cited by this paper
• Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial.

  2012cited by this paper
• Ancillary approaches to plasminogen activators

  2012cited by this paper
• A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.

  2012influential reference
• Sonothrombolysis for acute ischaemic stroke.

  2012cited by this paper
• Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial.

  2012cited by this paper
• Intravenous thrombolysis in acute ischaemic stroke: a systematic review and meta-analysis to aid decision making in patients over 80 years of age

  2011cited by this paper
• Letter by Hill et al regarding article, "A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke".

  2011cited by this paper
• Outcomes in Mild or Rapidly Improving Stroke Not Treated With Intravenous Recombinant Tissue-Type Plasminogen Activator: Findings From Get With The Guidelines–Stroke

  2011cited by this paper
• Validity of HAT Score for Predicting Symptomatic Intracranial Hemorrhage in Acute Stroke Patients with Proximal Occlusions: Data from Randomized Trials of Sonothrombolysis

  2011cited by this paper
• The Importance of Size: Successful Recanalization by Intravenous Thrombolysis in Acute Anterior Stroke Depends on Thrombus Length

  2011cited by this paper
• Does dementia increase risk of thrombolysis?

  2011cited by this paper
• Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States: A Doubling of Treatment Rates Over the Course of 5 Years

  2011cited by this paper
• A Cost–Utility Analysis of Mechanical Thrombectomy as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Large-Vessel Ischemic Stroke

  2011cited by this paper
• Mild stroke and rapidly improving symptoms: it's not always a happy ending.

  2011cited by this paper
• Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke: Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes

  2011cited by this paper
• Acute stroke therapy at the crossroads.

  2011cited by this paper
• Safety of Tirofiban in Acute Ischemic Stroke: The SaTIS Trial

  2011cited by this paper
• Randomised trials of endovascular treatment of stroke are needed.

  2010cited by this paper
• Changes in hemocoagulation in acute stroke patients after one-hour sono-thrombolysis using a diagnostic probe.

  2010cited by this paper
• Off-Label Thrombolysis Is Not Associated With Poor Outcome in Patients With Stroke

  2010cited by this paper
• Randomised trials of endovascular treatment of stroke are needed.

  2010cited by this paper
• Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

  2010cited by this paper
• Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive

  2010cited by this paper
• Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke: Results of a Prematurely Terminated Randomized Clinical Trial

  2010cited by this paper
• Safety and Efficacy of Ultrasound-Enhanced Thrombolysis: A Comprehensive Review and Meta-Analysis of Randomized and Nonrandomized Studies

  2010cited by this paper
• Acute ischemic stroke: Imaging-guided tenecteplase treatment in an extended time window

  2009influential reference
• Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact.

  2009cited by this paper
• Microbubbles for Thrombolysis of Acute Ischemic Stroke

  2009cited by this paper
• Acute ischemic stroke

  2009cited by this paper
• Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.

  2009cited by this paper
• Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

  2009cited by this paper
• Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies

  2008cited by this paper
• National US Estimates of Recombinant Tissue Plasminogen Activator Use: ICD-9 Codes Substantially Underestimate

  2008cited by this paper
• Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.

  2008cited by this paper
• The HAT Score

  2008cited by this paper
• The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke: The CLEAR Stroke Trial

  2008cited by this paper
• Changes in haemocoagulation in healthy volunteers after a 1-hour thrombotripsy using a diagnostic 2–4 MHz transcranial probe

  2008cited by this paper
• Do bubble characteristics affect recanalization in stroke patients treated with microbubble-enhanced sonothrombolysis?

  2008cited by this paper
• Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

  2008cited by this paper
• Quantification of Microspheres Appearance in Brain Vessels: Implications for Residual Flow Velocity Measurements, Dose Calculations, and Potential Drug Delivery

  2008cited by this paper
• Sonothrombolysis With Transcranial Color-Coded Sonography and Recombinant Tissue-Type Plasminogen Activator in Acute Middle Cerebral Artery Main Stem Occlusion: Results From a Randomized Study

  2008cited by this paper
• Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)

  2008cited by this paper
• Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

  2007cited by this paper
• Emergency Department Arrival Times after Acute Ischemic Stroke During the 1990s

  2007cited by this paper
• Outcome of Stroke With Mild or Rapidly Improving Symptoms

  2007cited by this paper
• Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke

  2007cited by this paper
• Population-Based Analysis of the Impact of Expanding the Time Window for Acute Stroke Treatment

  2007cited by this paper
• Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL): Pooled Analysis of T2*-Weighted Magnetic Resonance Imaging Data From 570 Patients

  2007cited by this paper
• Early Recanalization After Intravenous Administration of Recombinant Tissue Plasminogen Activator as Assessed by Pre- and Post-Thrombolytic Angiography in Acute Ischemic Stroke Patients

  2007cited by this paper
• The Impact of Recanalization on Ischemic Stroke Outcome: A Meta-Analysis

  2007cited by this paper
• Therapeutic applications of transcranial ultrasound devices

  2007cited by this paper
• Prevalence and severity of microbleeds in a memory clinic setting

  2006cited by this paper
• Argatroban tPA stroke study: study design and results in the first treated cohort.

  2006cited by this paper
• Why are eligible thrombolysis candidates left untreated?

  2006cited by this paper
• Barriers to Stroke Thrombolysis in a Geographically Defined Population

  2006cited by this paper
• Therapy of Basilar Artery Occlusion: A Systematic Analysis Comparing Intra-Arterial and Intravenous Thrombolysis

  2006cited by this paper
• Cardiovascular risk factors in patients aged 85 or older with ischemic stroke.

  2006cited by this paper
• Poststroke Dementia

  2006cited by this paper
• Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke.

  2006cited by this paper
• Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of Safety and Efficacy 3 to 9 Hours After Stroke Onset

  2006cited by this paper
• Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.

  2006cited by this paper
• Poststroke Dementia

  2005cited by this paper
• Sonothrombolysis in acute ischemic stroke for patients ineligible for rt-PA

  2005cited by this paper
• Ultrasound Enhanced Thrombolysis for Stroke

  2005cited by this paper
• Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of a Randomized Phase 2 Trial

  2005cited by this paper
• Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke

  2005cited by this paper

• Prognostic value of cardiac magnetic resonance imaging feature tracking technology in patients with light chain amyloidosis.

  2023cites this paper
• Transcranial Sonography as a Diagnostic Tool for Depressive Disorders

  2022cites this paper
• Treatments in Ischemic Stroke: Current and Future

  2022cites this paper
• Investigational drugs for ischemic stroke: what’s in the clinical development pipeline for acute phase and prevention?

  2022cites this paper
• Dodging blood brain barrier with “nano” warriors: Novel strategy against ischemic stroke

  2022cites this paper
• European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke

  2021cites this paper
• Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy

  2020cites this paper
• Transcranial Doppler Monitoring of Acute Reperfusion Therapies in Acute Ischemic Stroke Patients with Underlying Large Vessel Occlusions

  2020cites this paper
• Assessment of eligibility for thrombolysis in acute ischaemic stroke patients in Morocco

  2020influential citation
• Why not Intravenous Thrombolysis in Patients with Recurrent Stroke within 3 Months?

  2018cites this paper
• Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries

  2017cites this paper
• PHARMACOLOGICAL TREATMENT OF ACUTE ISCHEMIC STROKE: A REVIEW

  2017cites this paper
• Cerebral Microbleeds and Risk of Intracerebral Hemorrhage Post Intravenous Thrombolysis.

  2017cites this paper
• Functional magnetic resonance imaging in chronic ischaemic stroke

  2016cites this paper
• Pharmacological therapy of acute ischaemic stroke: Achievements and problems.

  2015cites this paper
• Combined Lysis of Thrombus with Ultrasound and Systemic Tissue Plasminogen Activator for Emergent Revascularization in Acute Ischemic Stroke (Clotbust-ER): Design and Methodology of a Multinational Phase 3 Trial

  2015cites this paper